MEGAN MOONEY: Open Payments
NPI 1417487802 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,122 in 296 payments from 22 companies in 2025. Trend: 2023 $2,775 · 2024 $4,316 · 2025 $6,122
Food & beverage: $5,873Education: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 98 | $1,709 |
| Janssen Biotech, Inc. | 44 | $1,120 |
| Novartis Pharmaceuticals Corporation | 37 | $567 |
| UCB, Inc. | 24 | $533 |
| Galderma Laboratories, L.P. | 17 | $306 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $277 |
| Incyte Corporation | 13 | $275 |
| Regeneron Healthcare Solutions, Inc. | 8 | $273 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $222 |
| GENZYME CORPORATION | 6 | $136 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, COSENTYX, DUPIXENT, OPZELURA, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
